Key facts
- This page summarizes Alexander Schornstein's Form 4 filing for ASSEMBLY BIOSCIENCES, INC. (ASMB).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 26 Nov 2024, 09:15.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Purchase
Purchase
Additional SEC filing notes
Footnote F1
The sales reported on this Form 4 represent shares purchased by the reporting person on November 22, 2024, from the open market using his personal funds.
Footnote F2
The price reported is the midpoint at which the shares were purchased. 17,024 shares were purchased on November 22, 2024, in multiple transactions at prices ranging from $14.735 to $15.00. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
Footnote F3
The sales reported on this Form 4 represent shares purchased by the reporting person on November 25, 2024, from the open market using his personal funds.
Footnote F4
2,976 shares were purchased on November 25, 2024 at $15.00.
Footnote F5
The sales reported on this Form 4 represent shares purchased by the reporting person on November 25, 2024, from the open market using his personal funds.
Footnote F6
The price reported is the midpoint at which the shares were purchased. 5,000 shares were purchased on November 25, 2024, in multiple transactions at prices ranging from $14.75 to 14.95. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.